The program is still filling in: the organizers list three tracks as under development and many talk titles as to be confirmed. We’ll add new sessions and the organizations presenting them as the agenda grows.

Universities and research institutes at World Vaccine Congress 2027

Mar 8–11, 2027 Washington, DC ~3k attendees Website

38 universities and research institutes are at World Vaccine Congress 2027 — 37 presentations on the program and 2 with a booth in the exhibit hall. Most represented: Boston Children's Hospital (3 on the program), University of Pennsylvania (3 on the program), Callen-Lorde (2 on the program). 8 of them have their own page in this guide. As of Oct 8, 2026.

All 222 organizations at World Vaccine Congress 2027 →

Showing 1–17 of 38 organizations

Organization	World Vaccine Congress 2027 Attendance
Boston Children's Hospital Boston, MA
childrenshospital.org Academic Pediatric teaching hospital of Harvard Medical School, home to the Precision Vaccines Program.	Talk Mon Mar 8 10:00 Vaccine Technology Workshop New vaccine technologies, from machine learning that pairs adjuvants with antigens to self-amplifying RNA and a liposome-adjuvanted malaria vaccine. with Montani Biotechnologies, Arcturus Therapeutics, Akagera Medicines +2 more Talk Wed Mar 10 09:10 Vaccine Safety Track: sessions to be announced with Johns Hopkins Bloomberg School of Public Health, Brighton Collaboration, Global Vaccine Data Network +1 more Talk Thu Mar 11 09:10 The Vanguard of Preparedness: Using Humanized In Vitro Systems to Predict Neonatal and Pediatric Immunogenicity for Outbreak Pathogens Pandemic Platforms Track
University of Pennsylvania Philadelphia, PA
upenn.edu Academic Research university whose Perelman School of Medicine pioneered the modified mRNA used in COVID-19 vaccines.	Talk Mon Mar 8 10:00 AMR Workshop How vaccines, antibodies and phage therapy can be developed, funded and used against drug-resistant bacteria, from infant infections to livestock. with Omniose, AMR Strategic Coalition, Gates Foundation +6 more Talk Wed Mar 10 12:30 The Exemption Expansion: Mandate Trends Under Trump II Vaccine Access Track Talk Thu Mar 11 09:40 Protective Pan-Betacoronavirus Neutralizing Antibodies by Vaccination Pandemic Platforms Track
Callen-Lorde New York, NY
callen-lorde.org Academic Community health center providing primary care and sexual health services to LGBTQ communities in New York City.	Talk Mon Mar 8 10:00 HIV Vaccines Workshop Where the search for an HIV vaccine stands, from laboratory advances and ongoing clinical trials to plans for fair global access. with Fred Hutch, IAVI, ModeX Therapeutics Keynote Thu Mar 11 14:20 Closing Keynote: Reimagining public health infrastructure in the USA – opportunities to rebuild with intention How the US could rebuild its public health system for the long term, from disease forecasting and biodefense to universal vaccine access. with Infectious Diseases Society of America, Manatt Health Supply, safety & access
National University of San Martín San Martín, Argentina
unsam.edu.ar Academic Argentine public university whose researchers developed ARVAC, a recombinant protein COVID-19 vaccine.	Talk Wed Mar 10 12:25 Phase IV results of the ARVAC vaccine, the first COVID-19 vaccine approved in South America and endorsed by PAHO Pandemic Platforms Track Talk Wed Mar 10 12:40 Immune Responses Induced by the ARVAC Booster Vaccine Following Phase IV Evaluation Immune Profiling Track
Albany Medical College Albany, NY
amc.edu Academic Medical school in Albany, New York, part of the Albany Med academic health system.	Talk Wed Mar 10 10:25 A Systemic OMV Prime–Mucosal Spike Strategy Generates Durable Lung-Resident Immunity Against Respiratory Bacterial Pathogens Immune Profiling Track
Baylor College of Medicine Houston, TX
bcm.edu Academic Medical school whose Texas Children's Hospital Center for Vaccine Development develops low-cost vaccines for neglected and emerging diseases.	Talk Mon Mar 8 10:00 Global Health Workshop How to move vaccines for poorer countries past long-standing roadblocks in development, and what shapes fair access in low-resource settings. with London School of Hygiene & Tropical Medicine, Think Vaccines, Gavi, the Vaccine Alliance +2 more Supply, safety & accessInfectious disease & AMR
Georgetown University Washington, DC
georgetown.edu Academic Private research university in Washington, DC, with schools of medicine, nursing, law and health policy.	Talk Wed Mar 10 09:10 Vaccine Safety Track: sessions to be announced with Boston Children's Hospital, Johns Hopkins Bloomberg School of Public Health, Brighton Collaboration +1 more
Global Vaccine Data Network Auckland, New Zealand
globalvaccinedatanetwork.org Academic International research network pooling health data across countries to study vaccine safety and effectiveness.	Talk Wed Mar 10 09:10 Vaccine Safety Track: sessions to be announced with Boston Children's Hospital, Johns Hopkins Bloomberg School of Public Health, Brighton Collaboration +1 more
University of Western Australia Perth, Australia
uwa.edu.au Academic Public research university in Perth, Western Australia.	Talk Wed Mar 10 12:10 MandEval Program - A mixed methods and multi-country study of the implementation and impact of COVID-19 vaccine mandates Vaccine Access Track
Mayo Clinic Rochester, MN
mayoclinic.org Academic Academic medical center whose Vaccine Research Group studies how people respond to vaccines and develops new ones.	Chair Tue Mar 9 09:00 Chair’s opening remarks Keynotes Talk Wed Mar 10 17:10 Deep Dive Session: From Vaccine R&D to Pandemic Prevention: What are the Use Cases for Broadly Protective Vaccines? When vaccines that protect against whole virus families could prevent pandemics, how much breadth is achievable, and how modeling guides their use. Chair Thu Mar 11 13:30 Chair’s opening remarks Keynotes
Weill Cornell Medicine New York, NY
weill.cornell.edu Academic Medical school of Cornell University in New York City.	Talk Wed Mar 10 09:25 New data in immune COP space for CMV, Non-human primate (NHP) models for congenital CMV Immune Profiling Track Panel Thu Mar 11 09:10 Panel: How to design trials for early life? / Unique challenges of clinical trial design for maternal-fetal transmission? How to design ethical and safe vaccine trials in pregnant people and newborns, including for group B streptococcus and neonatal herpes.
ACEGID Ede, Nigeria
acegid.org Academic African Centre of Excellence for Genomics of Infectious Diseases, using genomic sequencing for outbreak detection and response in Africa.	Keynote Tue Mar 9 09:30 Keynote Panel: Are We Ready for the Next Outbreak? Reconciling Surveillance, Diagnostics, and the MCM Pipeline How surveillance, diagnostics and regulators can work together to get vaccines deployed quickly in sudden outbreaks of viruses like Ebola and Marburg. with PATH, Africa CDC, International Vaccine Institute Infectious disease & AMR
City of Hope Duarte, CA
cityofhope.org Academic Cancer research and treatment center designated a comprehensive cancer center by the US National Cancer Institute.	Talk Wed Mar 10 10:10 Joint Presentation: Neoantigen-Based Cancer Vaccines: From Prediction to Clinical Translation Cancer & Immunotherapy Track · with myNEO Therapeutics
Cleveland Clinic Cleveland, OH
clevelandclinic.org Academic Academic medical center and hospital system whose research includes a preventive breast cancer vaccine.	Talk Wed Mar 10 12:40 Computationally optimized broadly reactive antigens for universal influenza protection Influenza & Respiratory Diseases Track
Emory University Atlanta, GA
emory.edu Academic Research university whose Emory Vaccine Center studies immune responses and develops vaccines.	Talk Wed Mar 10 12:10 Defining virus-host interactions that regulate immunity to Flavivirus infection / How RIG-I like receptors regulate B & T cell immunity/ How RIG-I like receptors can be targeted to serve as potential Immune Profiling Track
Fondazione Biotecnopolo di Siena Siena, Italy
biotecnopolo.it Academic Italian public foundation hosting the national pandemic preparedness centre, researching vaccines and monoclonal antibodies against emerging pathogens.	Talk Mon Mar 8 10:00 AMR Workshop How vaccines, antibodies and phage therapy can be developed, funded and used against drug-resistant bacteria, from infant infections to livestock. with Omniose, AMR Strategic Coalition, Gates Foundation +6 more
Fred Hutch Seattle, WA
fredhutch.org Academic Cancer and infectious disease research center whose vaccine and infectious disease division leads HIV vaccine trial networks.	Talk Mon Mar 8 10:00 HIV Vaccines Workshop Where the search for an HIV vaccine stands, from laboratory advances and ongoing clinical trials to plans for fair global access. with IAVI, Callen-Lorde, ModeX Therapeutics